Terms: = Prostate cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Staging
8 results:
1. Hypermethylation in the promoter region inhibits AJAP1 expression and activates the JAK/STAT pathway to promote prostate cancer cell migration and stem cell sphere formation.
Chen L; Wang Y; Zhang B
Pathol Res Pract; 2023 Jan; 241():154224. PubMed ID: 36566599
[TBL] [Abstract] [Full Text] [Related]
2. BTBD7 accelerates the epithelial-mesenchymal transition, proliferation and invasion of prostate cancer cells.
Chen B; Liu C; Bai G; Zhu Y; Xu H
J BUON; 2021; 26(5):2111-2116. PubMed ID: 34761624
[TBL] [Abstract] [Full Text] [Related]
3. MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.
Yan CQ; Lu YH; Tang SM; Fan WX
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2985-2990. PubMed ID: 29863241
[TBL] [Abstract] [Full Text] [Related]
4. Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.
Wang L; Li M; Zhan Y; Ban X; Zeng T; Zhu Y; Yun J; Guan XY; Li Y
Mol Carcinog; 2018 Jul; 57(7):886-895. PubMed ID: 29566278
[TBL] [Abstract] [Full Text] [Related]
5. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
Liu Y; Qin Z; Yang K; Liu R; Xu Y
Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
[TBL] [Abstract] [Full Text] [Related]
6. Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.
Satelli A; Batth IS; Brownlee Z; Rojas C; Meng QH; Kopetz S; Li S
Sci Rep; 2016 Jul; 6():28910. PubMed ID: 27363678
[TBL] [Abstract] [Full Text] [Related]
7. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract] [Full Text] [Related]
8. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
